Transgene Announces Opening of First Clinical Site for its
Phase II Trial of TG4040 for the Treatment of Chronic
Hepatitis C
http://www.transgene.fr/index.php?option=com_press_release&task=download&id=167&l=en
- Forums
- ASX - By Stock
- VHL
- phase ii trial of tg4040
VHL
vitasora health limited
Add to My Watchlist
0.00%
!
2.6¢

phase ii trial of tg4040
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.68M |
Open | High | Low | Value | Volume |
2.6¢ | 2.6¢ | 2.6¢ | $143.8K | 5.533M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 68000 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 220386 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 68000 | 0.025 |
7 | 902433 | 0.024 |
5 | 1074000 | 0.023 |
4 | 361000 | 0.022 |
6 | 483423 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 220386 | 3 |
0.028 | 497220 | 3 |
0.029 | 510563 | 2 |
0.030 | 869210 | 5 |
0.031 | 1222858 | 4 |
Last trade - 14.06pm 13/08/2025 (20 minute delay) ? |
Featured News
VHL (ASX) Chart |